Nuo Hua

Novartis is a leading global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine through innovative science and digital technologies. In the Chinese market, the company is widely recognized by its Chinese name, Nuo Hua (诺华), and maintains a robust presence through its commercial operations and the Novartis Institutes for BioMedical Research (NIBR) in Shanghai. The company's portfolio focuses on high-value innovative medicines across core therapeutic areas including oncology, cardiovascular, renal, and metabolic diseases, immunology, and neuroscience. Novartis is a pioneer in advanced therapy platforms, such as radioligand therapy, cell and gene therapy, and xRNA. With a pipeline of over 150 programs, the company continues to deliver transformative treatments like Kisqali, Entresto, and Zolgensma to patients worldwide. Novartis is committed to expanding access to healthcare and has a strong track record of strategic partnerships and academic collaborations.